Visceral injury · patients undergoing laparoscopy
It is very uncertain whether radially expanding trocars changes visceral injury compared with cutting trocars (very low certainty).
1 finding from 1 review
Visceral injury · patients undergoing laparoscopy
1 finding from 1 review
Visceral injury · patients undergoing laparoscopy
1 finding from 1 review
Visceral injury · patients undergoing laparoscopy
1 finding from 1 review
Criminal activity ‐ Re‐incarceration · drug‐using offenders
Summary of findings for the main comparisons: Agonist pharmacological showed no clear difference in criminal activity dichotomous ‐ Re‐incarceration official records compared with no intervention (low certainty).
1 finding from 1 review
Criminal activity dichotomous ‐ Reincarceration official records · patients with drug‐using offenders
Summary of findings for the main comparisons: Antagonost (Naltrexone) probably leads to lower criminal activity dichotomous ‐ Reincarceration official records compared with no pharmacological (moderate certainty).
1 finding from 1 review
Duration and pain of oral ulceration · People with Behcet's disease with a history of recurrent oral aphthous-type (RAS-type) ulcers diagnosed clinically; primary care
1 finding from 1 review
Alpsoy 2002 (subcutaneous interferon-alpha 6 x 10^6 IU 3x/week for 3 months vs placebo, 50 patients; high risk of reporting bias): data were not presented in a usable format; authors reported a statistically…
1 study · 50 participants
GRADE not reported
Nose ulceration or bleeding · children with acute lower respiratory tract infections
Nasal prongs showed no clear difference in nose ulceration or bleeding compared with nasopharyngeal catheter (low certainty).
1 finding from 1 review
Symptom scores of ulceration subtype Graded by 4 levels1 · patients with functional dyspepsia
It is very uncertain whether manual‐electroacupuncture changes symptom scores of ulceration subtype Graded by 4 levels1 compared with domperidone (very low certainty).
1 finding from 1 review
Duration to heal oral ulcerations after initiation of treatment · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
The review found no eligible studies for this question.
1 finding from 1 review
Duration to heal oral ulcerations after initiation of treatment · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
The review found no eligible studies for this question.
1 finding from 1 review
Healing of ulceration · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
The review found no eligible studies for this question.
1 finding from 1 review
Healing of ulceration · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
The review found no eligible studies for this question.
1 finding from 1 review
Healing of ulceration · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
The review found no eligible studies for this question.
1 finding from 1 review
Physician Global Assessment (weighted sums of ulceration, erythema, reticulation, mm2) · People with erosive oral lichen planus
1% pimecrolimus cream showed no clear difference in physician Global Assessment (weighted sums of ulceration, erythema,… compared with placebo (vehicle cream); GRADE not reported.
1 finding from 1 review
Duration to heal oral ulcerations after initiation of treatment · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
The review found no eligible studies for this question.
1 finding from 1 review
Healing of ulceration · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
The review found no eligible studies for this question.
1 finding from 1 review
Duration to heal oral ulcerations after initiation of treatment · HIV‐infected adults (> 13 years of age, per CDC) with one or more painful intraoral aphthous ulcers
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to adverse events · Patients with active mild to moderate ulcerative colitis
It is very uncertain whether inulin and oligofructose 15 g changes withdrawals due to adverse events (9 weeks) compared with inulin and oligofructose 7.5 g daily (very low certainty).
1 finding from 1 review
Clinical remission · Patients with active mild to moderate ulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found